跳至主要内容
临床试验/NL-OMON50787
NL-OMON50787已完成4 期

Effect of citalopram on chest pain in patients with functional chest pain - Ci-FCP

Academisch Medisch Centrum0 个研究点目标入组 54 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
54

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • * Written informed consent
  • * Minimum age: 18 years
  • * Functional chest pain according to Rome IV criteria
  • * Ruled out cardiac origin of chest pain
  • * ECG with corrected QT interval (QTc) within the normal range (<450ms male,
  • <460ms female)
  • * Symptoms of chest pain for at least 6 months
  • * Frequency of symptoms at least once a week
  • * Gastroduodenoscopy, high-resolution manometry and 24-hour pH-impedance
  • monitoring need to have been performed recently.

排除标准

  • * Currently using antidepressants
  • * Contraindication for the use of SSRI
  • * Already tried antidepressants off-label to treat chest pain
  • * Known allergy to citalopram
  • * Severe and clinically unstable concomitant disease
  • * Pregnant, lactating or fertile women (without contraception)

研究者

相似试验